Literature DB >> 24737461

Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells.

Yaming Wang1, Marco Colonna.   

Abstract

IL-34 is a recently discovered cytokine that acts on tissue resident macrophages and Langerhans cells upon binding the receptor for CSF-1, CSF-1R. The existence of two ligands for CSF-1R, IL-34, and CSF-1, raises several intriguing questions. Are IL-34 and CSF-1 redundant or does each perform temporally and spatially distinct functions? Is IL-34 involved in human pathology? Would therapeutic strategies based on selective inhibition or administration of either IL-34 or CSF-1 be advantageous for preventing human pathology? Recent in vivo studies indicate that IL-34 promotes the development, survival, and function of microglia and Langerhans cells; therefore, this cytokine may predominately function in brain and skin biology. Here, we review the evidence for IL-34 as a key cytokine in the development and function of these two diverse cell types and discuss its potential role in pathological conditions.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CSF-1; IL-34; Langerhans cell; M-CSF; Macrophage; Microglia; Osteoclast

Mesh:

Substances:

Year:  2014        PMID: 24737461      PMCID: PMC4137395          DOI: 10.1002/eji.201344365

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  63 in total

1.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

2.  Two distinct types of Langerhans cells populate the skin during steady state and inflammation.

Authors:  Kristin Seré; Jea-Hyun Baek; Julia Ober-Blöbaum; Gerhard Müller-Newen; Frank Tacke; Yoshifumi Yokota; Martin Zenke; Thomas Hieronymus
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

3.  Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34.

Authors:  Sayan Nandi; Mario Cioce; Yee-Guide Yeung; Edward Nieves; Lydia Tesfa; Haishan Lin; Amy W Hsu; Robert Halenbeck; Hui-Yong Cheng; Solen Gokhan; Mark F Mehler; E Richard Stanley
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

4.  Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.

Authors:  Ye Tian; Hui Shen; Liping Xia; Jing Lu
Journal:  J Interferon Cytokine Res       Date:  2013-02-19       Impact factor: 2.607

Review 5.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

6.  Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor.

Authors:  Jan Felix; Jonathan Elegheert; Irina Gutsche; Alexander V Shkumatov; Yurong Wen; Nathalie Bracke; Erwin Pannecoucke; Isabel Vandenberghe; Bart Devreese; Dmitri I Svergun; Ewald Pauwels; Bjorn Vergauwen; Savvas N Savvides
Journal:  Structure       Date:  2013-03-07       Impact factor: 5.006

7.  Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation.

Authors:  Ruteja A Barve; Marc D Zack; David Weiss; Ruo-Hua Song; David Beidler; Richard D Head
Journal:  Cytokine       Date:  2013-05-14       Impact factor: 3.861

8.  IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.

Authors:  Francesco Ciccia; Riccardo Alessandro; Vito Rodolico; Giuliana Guggino; Stefania Raimondo; Carla Guarnotta; AnnaRita Giardina; Guido Sireci; Giuseppina Campisi; Giacomo De Leo; Giovanni Triolo
Journal:  Rheumatology (Oxford)       Date:  2013-02-07       Impact factor: 7.580

Review 9.  Tissue macrophage heterogeneity: issues and prospects.

Authors:  Siamon Gordon; Annette Plűddemann
Journal:  Semin Immunopathol       Date:  2013-06-20       Impact factor: 9.623

10.  Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.

Authors:  Jian Luo; Fiona Elwood; Markus Britschgi; Saul Villeda; Hui Zhang; Zhaoqing Ding; Liyin Zhu; Haitham Alabsi; Ruth Getachew; Ramya Narasimhan; Rafael Wabl; Nina Fainberg; Michelle L James; Gordon Wong; Jane Relton; Sanjiv S Gambhir; Jeffrey W Pollard; Tony Wyss-Coray
Journal:  J Exp Med       Date:  2013-01-07       Impact factor: 14.307

View more
  37 in total

1.  Transplant tolerance: a new role for IL-34.

Authors:  James I Kim; Laurence A Turka
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 2.  Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Jessica A Goularte; Fabricia Petronilho; Priyanka Saigal; Marwa Badawy; João Quevedo
Journal:  Mol Neurobiol       Date:  2015-03-07       Impact factor: 5.590

3.  Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages.

Authors:  Amulya Yaparla; Milan Popovic; Leon Grayfer
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 4.  Functions of interleukin-34 and its emerging association with rheumatoid arthritis.

Authors:  Ren-Peng Zhou; Xiao-Shan Wu; Ya-Ya Xie; Bei-Bei Dai; Wei Hu; Jin-Fang Ge; Fei-Hu Chen
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

Review 5.  Immunoregulatory properties of the cytokine IL-34.

Authors:  Carole Guillonneau; Séverine Bézie; Ignacio Anegon
Journal:  Cell Mol Life Sci       Date:  2017-03-03       Impact factor: 9.261

6.  Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.

Authors:  Chun-Hsien Chu; Shijun Wang; Chia-Ling Li; Shih-Heng Chen; Chih-Fen Hu; Yi-Lun Chung; Shiou-Lan Chen; Qingshan Wang; Ru-Band Lu; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Brain Behav Immun       Date:  2016-04-27       Impact factor: 7.217

7.  Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation.

Authors:  Yaming Wang; Mattia Bugatti; Tyler K Ulland; William Vermi; Susan Gilfillan; Marco Colonna
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

Review 8.  Amphibian macrophage development and antiviral defenses.

Authors:  Leon Grayfer; Jacques Robert
Journal:  Dev Comp Immunol       Date:  2015-12-15       Impact factor: 3.636

9.  Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Leukoc Biol       Date:  2014-09-04       Impact factor: 4.962

10.  Cell-Surface and Secreted Isoforms of CSF-1 Exert Opposing Roles in Macrophage-Mediated Neural Damage in Cx32-Deficient Mice.

Authors:  Janos Groh; Ranu Basu; E Richard Stanley; Rudolf Martini
Journal:  J Neurosci       Date:  2016-02-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.